Aleck Jones

CEO at Kindling Bio

Speaker

Aleck Jones, PhD, is CEO and Co-Founder of Kindling Bio, an award-winning London-based biotech pioneering a fundamentally different approach to immunotherapy for childhood cancer and beyond. With nearly 20 years’ experience in cancer biology and child health at University College London and King’s College London, he leads Kindling Bio in building an engineered viral gene therapy platform that puts children first in oncology and turns neglected paediatric cancers into scalable, commercially viable markets for curative therapies.